Swiss National Bank Has $813,000 Holdings in Viewray Inc (VRAY)
Swiss National Bank lifted its stake in shares of Viewray Inc (NASDAQ:VRAY) by 67.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 86,900 shares of the company’s stock after acquiring an additional 35,000 shares during the period. Swiss National Bank owned approximately 0.12% of Viewray worth $813,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of VRAY. Fosun International Ltd lifted its holdings in shares of Viewray by 27.9% during the 2nd quarter. Fosun International Ltd now owns 13,768,556 shares of the company’s stock worth $95,278,000 after acquiring an additional 3,000,581 shares during the last quarter. FMR LLC lifted its holdings in shares of Viewray by 36.9% during the 2nd quarter. FMR LLC now owns 7,670,767 shares of the company’s stock worth $53,082,000 after acquiring an additional 2,069,086 shares during the last quarter. BlackRock Inc. lifted its holdings in shares of Viewray by 59.3% during the 2nd quarter. BlackRock Inc. now owns 2,962,937 shares of the company’s stock worth $20,503,000 after acquiring an additional 1,102,991 shares during the last quarter. Artisan Partners Limited Partnership bought a new stake in shares of Viewray during the 2nd quarter worth $6,852,000. Finally, Frontier Capital Management Co. LLC bought a new stake in shares of Viewray during the 3rd quarter worth $7,320,000. 98.28% of the stock is owned by institutional investors.
In other Viewray news, CEO Scott William Drake bought 60,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 13th. The shares were bought at an average price of $6.47 per share, for a total transaction of $388,200.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Shahriar Matin bought 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 13th. The stock was acquired at an average price of $6.47 per share, for a total transaction of $161,750.00. The disclosure for this purchase can be found here. 43.93% of the stock is owned by company insiders.
Shares of NASDAQ:VRAY opened at $6.46 on Friday. The firm has a market capitalization of $605.97 million, a P/E ratio of -6.21 and a beta of 1.10. Viewray Inc has a 52 week low of $5.80 and a 52 week high of $13.21. The company has a debt-to-equity ratio of 0.25, a quick ratio of 5.56 and a current ratio of 6.47.
Viewray (NASDAQ:VRAY) last issued its earnings results on Thursday, November 8th. The company reported ($0.39) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.17). The business had revenue of $17.70 million during the quarter, compared to analysts’ expectations of $17.77 million. Viewray had a negative return on equity of 105.63% and a negative net margin of 105.09%. Viewray’s revenue for the quarter was up 45.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.19) EPS. As a group, equities analysts forecast that Viewray Inc will post -0.87 earnings per share for the current fiscal year.
Viewray Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Further Reading: How are Outstanding Shares Different from Authorized Shares?
Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.